BRNS · Barinthus Biotherapeutics plc.
$0.57
+0.00 (+0.65%)
At close · Jul 29
Market Cap
$23.44M
Shares
40.85M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$27,000,000
as of 2026-06-30
Equity Offering (ATM) Programs
| Program Established | Capacity | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2022-08-09 | $75,000,000 | — | 2025-11-07 | 2025-08-17 expired | 10-Q , filed 2025-11-07 |